Atogepant for preventing migraine (TA973)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 15 May 2024
Botulinum toxin type A for preventing episodic migraine ID 6450Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
CT guided fibrin glue sealing of CSf leak to treat spontaneous intracranial hypotensionStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Migraine trigger site deactivation surgeryStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Upadacitinib for treating giant cell arteritis [ID6299]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Zavegepant for treating acute migraine TSID 11998Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC